Interventions for valvular disease and heart failure

Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry

EuroIntervention 2016;11:e1649-e1657 published online e-edition April 2016. DOI: 10.4244/EIJV11I14A316

Yohei Ohno
Yohei Ohno1,2, MD; Guilherme F. Attizzani1,3, MD; Davide Capodanno1,4, MD, PhD; Marco Barbanti1, MD; Stefano Cannata1, MD; Fabio Dipasqua1, MD; Sebastiano Immé1, MD; Margherita Ministeri1, MD; Anna Caggegi1, MD; Anna M. Pistritto1, MD; Marta Chiarandà1, MD; Giuseppe Ronsivalle1, MD; Sandra Giaquinta1, MD; Sarah Mangiafico1, MD; Salvatore Scandura1, MD; Piera Capranzano1,4, MD, PhD; Corrado Tamburino1,4, MD, PhD; Carmelo Grasso1*, MD
1. Department of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy; 2. Department of Cardiology, Tokai University School of Medicine, Isehara, Japan; 3. The Valve and Structural Heart Intervention Center, Harrington Heart and Vascular

Aims: Our aim was to evaluate the impact of baseline chronic kidney disease (CKD) on clinical outcomes after percutaneous edge-to-edge mitral valve repair (PMVR).

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

chronic kidney diseasemitraclipmitral regurgitationmitral valve calcificationpercutaneous mitral valve repair
Interventions for valvular diseaseMitral valve replacement and repair
Read next article
RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation

Latest news